wsbdaily | Mon, 26 Sep 2022 03:58:40 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Cassava Sciences, Inc.(SAVA)
Cassava Sciences, Inc.
7801 North Capital of Texas Highway
Suite 260
Austin, TX 78731
United States
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.... Read More
Summary & Charts
| Price | $ 41.87 | -9.19 (-18%) |
| Day's Range | $ 38.11 - 44.62 | |
| Previous Close | $ 51.06 | |
| Market Cap | $ 1.68B USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqCM | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 13.83M | |
| Avg. Volume (20 day) | 4.25M | |
| Rel. Volume (20 day) | 3.26 | |
| Rel. Volume (3 month) | 4.22 | |
| Rating | B+ | Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 2.99 % | Neutral |
| ROE | -17.93 % | Neutral |
| ROA | -19.07 % | Neutral |
| P/E | -36.07 % | Strong Sell |
| P/B | 7.06 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2022 | $ 38.35 | $ 44.62 | $ 38.11 | $ 41.87 | -9.19 | 13,831,834 | 3.26 | 4.22 | 42 |
| Sep 22, 2022 | $ 37.92 | $ 51.59 | $ 36.88 | $ 51.06 | +13.42 | 23,647,627 | 6.38 | 7.75 | 107 |
| Sep 21, 2022 | $ 37.71 | $ 41.24 | $ 36.11 | $ 37.64 | -1.27 | 7,190,592 | 2.68 | 2.69 | 7 |
| Sep 20, 2022 | $ 30.01 | $ 39.73 | $ 29.70 | $ 38.91 | +8.61 | 7,564,783 | 3.08 | 2.94 | 35 |
| Sep 19, 2022 | $ 30.68 | $ 31.23 | $ 29.70 | $ 30.30 | -0.74 | 1,149,161 | 0.53 | 0.46 | 1 |
| Sep 16, 2022 | $ 31.00 | $ 32.44 | $ 30.20 | $ 31.04 | -0.54 | 1,258,097 | 0.56 | 0.52 | 1 |
| Sep 15, 2022 | $ 32.80 | $ 33.60 | $ 31.54 | $ 31.58 | -1.34 | 1,128,702 | 0.36 | 0.47 | 3 |
| Sep 14, 2022 | $ 30.56 | $ 33.03 | $ 29.51 | $ 32.92 | +2.05 | 1,748,007 | 0.36 | 0.74 | 2 |
| Sep 13, 2022 | $ 32.00 | $ 35.58 | $ 30.82 | $ 30.87 | -2.51 | 2,707,581 | 0.56 | 1.15 | 5 |
| Sep 12, 2022 | $ 34.39 | $ 34.40 | $ 31.82 | $ 33.38 | +0.58 | 1,711,689 | 0.36 | 0.70 | 3 |
| Sep 09, 2022 | $ 30.08 | $ 33.50 | $ 29.50 | $ 32.80 | +3.19 | 3,322,640 | 0.70 | 1.38 | 10 |
| Sep 08, 2022 | $ 29.55 | $ 30.13 | $ 28.55 | $ 29.61 | +0.29 | 1,268,596 | 0.27 | 0.53 | 2 |
| Sep 07, 2022 | $ 28.15 | $ 30.80 | $ 28.01 | $ 29.32 | +0.96 | 2,415,724 | 0.52 | 1.00 | 5 |
| Sep 06, 2022 | $ 25.04 | $ 28.72 | $ 25.04 | $ 28.36 | +3.68 | 2,951,429 | 0.65 | 1.22 | 12 |
| Sep 02, 2022 | $ 25.50 | $ 25.52 | $ 24.40 | $ 24.68 | -0.66 | 933,987 | 0.20 | 0.39 | 4 |
| Sep 01, 2022 | $ 25.56 | $ 25.92 | $ 24.91 | $ 25.34 | -0.39 | 1,011,905 | 0.22 | 0.42 | 3 |
| Aug 31, 2022 | $ 26.09 | $ 26.49 | $ 24.82 | $ 25.73 | -0.51 | 1,161,326 | 0.25 | 0.47 | 4 |
| Aug 30, 2022 | $ 26.82 | $ 27.44 | $ 25.08 | $ 26.24 | +0.12 | 1,870,250 | 0.39 | 0.76 | 11 |
| Aug 29, 2022 | $ 28.58 | $ 30.30 | $ 25.17 | $ 26.12 | -3.27 | 3,364,221 | 0.70 | 1.36 | 8 |
| Aug 26, 2022 | $ 30.12 | $ 30.34 | $ 28.10 | $ 29.39 | +2.11 | 4,671,035 | 0.97 | 1.90 | 13 |
News
The latest news about Cassava Sciences, Inc. (SAVA).
InvestorPlace | 2022-09-23 14:14:27
Shares of Cassava Sciences (NASDAQ: SAVA ) are down by over 15% following the previous day's gain of 35%. Yesterday, the Securities and Exchange Commission (SEC) announced that it had closed its case on Cassava.
Seeking Alpha | 2022-09-22 17:44:00
Initiation of a phase 3 program open-label extension study using Simufilam for patients with Alzheimer's Disease is expected in 2nd half of 2022. An ongoing long-term open label study, initiated in March of 2020 is ongoing; Dosing completion is expected Q4 of 2022 and results from it are expected before end of 2022.
InvestorPlace | 2022-09-22 16:45:37
Deleted: Despite a significant down day for the S&P 500, shares of Cassava Sciences (NASDAQ: SAVA ) closed higher by 35%. That's because the Securities and Exchange Commission (SEC) has closed its case on Cassava following the initiation of an investigation last November.
Investors Business Daily | 2022-09-22 15:06:54
The SEC reportedly cleared an investigation into Cassava Sciences, leading SAVA stock to hit a seven-month high Thursday. The post Cassava Skyrockets After SEC Clears It Of Tampering With Alzheimer's Data appeared first on Investor's Business Daily.
Seeking Alpha | 2022-09-22 08:00:00
Cassava Sciences increased by over 10% intraday on positive SEC news. Cassava Sciences is up 26% in the last month while the market is down 7%.
InvestorPlace | 2022-09-21 09:36:01
Cassava Sciences (NASDAQ: SAVA ) stock rose nearly 30% on Sept. 20 as speculators bet on the company's efforts against Alzheimer's Disease.
GlobeNewsWire | 2022-09-08 09:15:00
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held in New York.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | BMO | -0.48 | -- | -- | -- | -- | -- |
| 2022-08-03 | BMO | -0.43 | -0.48 | 11.62% | -- | -- | -- |
| 2022-05-05 | BMO | -0.41 | -0.44 | 7.31% | -- | -- | -- |
| 2022-02-28 | BMO | -0.33 | -0.35 | 6.06% | -- | -- | -- |
| 2021-11-10 | BMO | -0.17 | -0.24 | 41.17% | -- | -- | -- |
| 2021-08-03 | BMO | -0.11 | -0.13 | 18.18% | -- | -- | -- |
| 2021-04-21 | BMO | -0.1 | -0.09 | 10% | -- | -- | -- |
| 2020-11-09 | BMO | -0.07 | -0.06 | 14.29% | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the SAVA stock ticker symbol.
Weekend Discussion Thread for the Weekend of September 24, 2022
**Read [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide), follow [Twitter](https://twitter.com/Official_WSB) and [IG](https://www.instagram.com/official_wallstreetbets/), join [Discor... Read More
- (4 points) Closed out my puts and locked in the gains. Up 280% (~$13k -> $36k). Still in the hole ~$3k for the year after some shitty bets on 3M and gold while I was just getting started with trading. Still holding a couple puts on $SAVA and $HYG. Might pick up a couple here and there if I see obvious winners but I'm staying away from indexes for a bit until we see where the dollar is headed next week.
- (2 points) SAVA - up big or crashing down next week?
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| CALL | $ 42.00 | 09/29/22 | 5 | $ 4.05 | $ 4.55 | $ 4.24 | 1,234 | 241 | 5.12 | 1.89% |
| CALL | $ 43.00 | 09/29/22 | 5 | $ 3.65 | $ 4.15 | $ 3.75 | 304 | 183 | 1.66 | 1.90% |
| CALL | $ 44.00 | 09/29/22 | 5 | $ 3.25 | $ 3.85 | $ 3.40 | 294 | 46 | 6.39 | 1.92% |
| CALL | $ 45.00 | 09/29/22 | 5 | $ 3.10 | $ 3.50 | $ 3.25 | 1,997 | 556 | 3.59 | 1.97% |
| CALL | $ 48.00 | 09/29/22 | 5 | $ 2.22 | $ 2.78 | $ 2.57 | 309 | 210 | 1.47 | 2.01% |
| CALL | $ 50.00 | 09/29/22 | 5 | $ 1.86 | $ 2.37 | $ 2.10 | 3,558 | 2,043 | 1.74 | 2.06% |
| CALL | $ 55.00 | 09/29/22 | 5 | $ 1.00 | $ 1.71 | $ 1.35 | 1,544 | 1,232 | 1.25 | 2.13% |
| PUT | $ 35.00 | 09/29/22 | 5 | $ 1.52 | $ 1.89 | $ 1.70 | 1,408 | 469 | 3.00 | 2.03% |
| CALL | $ 41.00 | 10/06/22 | 12 | $ 5.30 | $ 6.30 | $ 5.65 | 20 | 13 | 1.54 | 1.66% |
| CALL | $ 42.00 | 10/06/22 | 12 | $ 4.90 | $ 5.65 | $ 6.08 | 61 | 24 | 2.54 | 1.64% |
| PUT | $ 25.00 | 10/06/22 | 12 | $ 0.50 | $ 0.71 | $ 0.65 | 272 | 188 | 1.45 | 2.05% |
| PUT | $ 34.00 | 10/06/22 | 12 | $ 2.13 | $ 2.88 | $ 3.20 | 16 | 11 | 1.45 | 1.90% |
| PUT | $ 30.00 | 10/13/22 | 19 | $ 1.70 | $ 2.30 | $ 2.31 | 128 | 42 | 3.05 | 1.84% |
| CALL | $ 22.50 | 10/20/22 | 26 | $ 18.20 | $ 20.10 | $ 21.83 | 50 | 17 | 2.94 | 1.78% |
| PUT | $ 150.00 | 01/19/23 | 117 | $ 113.00 | $ 118.00 | $ 120.70 | 20 | 11 | 1.82 | 2.23% |
| PUT | $ 22.50 | 01/18/24 | 481 | $ 10.60 | $ 11.05 | $ 10.25 | 110 | 83 | 1.33 | 1.49% |
Last Updated: Fri, 23 Sep 2022 22:54 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 14 Dec 2021 12:00 EST
@wsbdaily
wsbdaily